Skip to main content
Equibles
CPIX logo

CPIX · Cumberland Pharmaceuticals Inc

Track CPIX — free

Use CPIX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$6.79 +0.04 (+0.59%) At close · Sep 4
Rebalance outlook locked
Market Cap
$101.74M
Shares
14.98M

CPIX metrics

69 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$6.79
Market cap
$101.74M

Price action

19 metrics
Price change (1W)
-19.7%
Price change (30D)
-12.9%
Price change (3M)
+17.1%
Price change (6M)
+94.0%
Price change (YTD)
+70.6%
Price change (1Y)
+85.5%
Trailing year
Price change (5Y)
+141.6%
52-week high
$8.97
52-week low
$1.90
Change from 52-week high
-24.3%
Change from 52-week low
+257.4%
Annualized volatility
88.3%
Beta
0.9
RSI (14D)
42.0
Price vs SMA 50
-6.0%
Price vs SMA 200
+41.3%
Avg volume (3M)
91,410
Relative volume
0.2
Average dollar volume
$646,160

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
14.98M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.3×
reciprocal yield 30.7%
P / book
5.8
reciprocal yield 17.1%
FCF yield
—
TTM · current market cap
Buyback yield
0.1%
P / FCF
—
P / operating cash flow
136.4
reciprocal yield 0.7%
Earnings yield
-10.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
22.1%
Trailing 12 months
Payout ratio
—
Shareholder yield
0.1%
Dividend / share (TTM)
$1.50
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2026-08-03

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
85.0%
Operating margin
-30.8%
Trailing 12 months
Net margin
-34.9%
Gross profit (TTM)
—
Operating profit (TTM)
−$9.63M
Net income (TTM)
−$10.92M
Trailing 12 months
Diluted EPS (TTM)
$-0.73
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$3.82

Growth

11 metrics
Revenue growth YoY
-56.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$31.27M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.1%
Year over year · more shares
Revenue CAGR (3Y)
+2.0%
Revenue CAGR (5Y)
+3.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-16.7%
FCF CAGR (5Y)
-1.7%

Quality

14 metrics
Return on equity
-62.6%
Return on assets
-17.4%
Debt / equity
—
Current ratio
1.0
EBITDA (TTM)
$1.10M
Free cash flow (TTM)
—
Quick ratio
1.0
Interest coverage
-23.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$3.86M
Total assets
$62.88M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$745,969
Capital expenditures (TTM)
$62,070
R&D (TTM)
$5.66M
SG&A (TTM)
—
Stock compensation (TTM)
$438,130
R&D / revenue
18.1%
Stock compensation / revenue
1.4%

Ownership (13F)

3 metrics
13F filers
33
13F filer change QoQ
+3
Institutional ownership
18.9%

Short interest

3 metrics
Short interest
2.2%
Latest settlement · 2.7 days to cover
Days to cover
2.7d
Short-squeeze score
51 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1087294 CUSIP 230770109 13F (30d) 26 filings 26 filers Visit website Investor relations